Skip to main content
SpringerLink
Log in

Further Statistical Issues in Project Prioritization in the Pharmaceutical Industry

  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

Various aspects of portfolio management within the pharmaceutical industry are considered. It is shown that some popular notions of risk management are incorrect. Some additional practical matters are also touched upon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Chapter © 2019

References

  1. Senn SJ. Some statistical issues in project prioritization in the pharmaceutical industry. Stat Med. 1996; 15:2689–2702.

    Article  CAS  Google Scholar 

  2. Gittins JC. Quantitative methods in the planning of pharmaceutical research. Drug Inf J. 1996;30:479–487.

    Article  Google Scholar 

  3. Pearson AW. The use of ranking formulae in R&D projects. R&D Manage. 1972;2:69–73.

    Article  Google Scholar 

  4. Dixit AK, Pindyck RS. Investment Under Uncertainty. Princeton: Princeton University Press; 1994.

    Book  Google Scholar 

  5. Owen D. Selecting projects to obtain a balanced research portfolio. In: Howard RA, Matheson JE, eds. The Principles and Applications of Decision Analysis. Menlo Park: Strategic Decisions Group; 1989.

    Google Scholar 

  6. Markowitz H. Portfolio selection. J Finance. 1952;7:77–91.

    Google Scholar 

  7. O’Hagan A. Probability Methods and Measurement. London and New York: Chapman and Hall; 1987.

    Google Scholar 

  8. Hill T. Calculating the cost of clinical research. Scrip Magazine. 1994;March:28-30.

    Google Scholar 

  9. Gittins JC. A planning procedure for new-product chemical research. R&D Manage. 1994;24:219–227.

    Article  Google Scholar 

  10. Hull JC. Options, Futures and Other Derivative Securities. Eaglewood Cliffs, NJ: Prentice-Hall; 1989.

Download references

Author information

Authors and Affiliations

  1. Department of Statistical Science and Department of Epidemiology and Community Health, University College London, London, UK

    Stephen Senn BA, MSc, PhD (Professor of Pharmaceutical and Health Statistics)

Authors
  1. Stephen Senn BA, MSc, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen Senn BA, MSc, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senn, S. Further Statistical Issues in Project Prioritization in the Pharmaceutical Industry. Ther Innov Regul Sci 32, 253–259 (1998). https://doi.org/10.1177/009286159803200133

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286159803200133

Key Words

Search

Navigation